Nonylphenol and octylphenol in prostate cancer: bioinformatics identification of ABCC4/CDK4 and functional verification for nonylphenol

Introduction Endocrine-disrupting chemicals (EDCs) like nonylphenol (NP) and octylphenol (OP) are linked to prostate cancer (PCa) risk, but molecular mechanisms remain unclear. This work aimed to dissect how NP and OP drive PCa pathogenesis. Methods Bulk and single-cell transcriptomics were combined with network toxicology, Mendelian randomization (MR), machine learning and molecular docking. Candidate genes were screened by intersection analysis, and causal relationships were evaluated via MR. Multiple machine learning algorithms identified robust biomarkers, which were further validated in external cohorts. Single-cell transcriptome profiling, functional enrichment and molecular docking were performed, followed by in vitro cellular assays. Results We identified 29 overlapping PCa-related targets of NP and OP, among which CDK4, AR, CDKN2A and ABCC4 were prioritized. MR suggested potential causal associations for ABCC4 (OR=1.02, p=0.006) and CDK4 (OR=1.14, p=0.04) with PCa risk. Machine learning (LASSO/SVM-RFE/Boruta) consistently selected ABCC4 and CDK4 as robust biomarkers, validated across independent cohorts. Single-cell analysis of 90,140 cells revealed 15 cell types, with significant expansion of myeloid dendritic cells (mDCs) in tumors. Both biomarkers showed dynamic expression along mDCs differentiation trajectories. Gene enrichment implicated focal adhesion, xenobiotic metabolism, and cell cycle pathways. Molecular docking predicted favorable binding poses for NP and OP with ABCC4 and CDK4, with binding energies below -4.5 kcal/mol. In vitro experiments confirmed that NP promoted PCa cell migration, while OP had no significant effect on cell proliferation. Conclusion ABCC4 and CDK4 may serve as candidate mediators connecting NP/OP exposure with PCa. The expansion and metabolic reprogramming of mDCs suggest that mDCs may participate in tumor microenvironment remodeling in NP/OP-associated PCa. These findings provide molecular insights for environmental PCa prevention and highlight intervention targets.

Authors

Institutions

Publication Details

Journal
Frontiers in Public Health
Published
2026-11-17
DOI
https://doi.org/10.3389/fpubh.2026.2007850
Primary Topic
Effects and risks of endocrine disrupting chemicals
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Nonylphenol and octylphenol in prostate cancer: bioinformatics identification of ABCC4/CDK4 and functional verification for nonylphenol

Yong Zhu, Ying Bi, ChongJian Zhang, Hong Yang et al.
3 links
Frontiers in Public Health
Effects and risks of endocrine disrupting chemicals
article

Nonylphenol and octylphenol in prostate cancer: bioinformatics identification of ABCC4/CDK4 and functional verification for nonylphenol

Yong Zhu, Ying Bi, ChongJian Zhang, Hong Yang, Zijian Tan, Ziyong Wang, Yu Bai, Haiyang Jiang
article en

Abstract

Introduction Endocrine-disrupting chemicals (EDCs) like nonylphenol (NP) and octylphenol (OP) are linked to prostate cancer (PCa) risk, but molecular mechanisms remain unclear. This work aimed to dissect how NP and OP drive PCa pathogenesis. Methods Bulk and single-cell transcriptomics were combined with network toxicology, Mendelian randomization (MR), machine learning and molecular docking. Candidate genes were screened by intersection analysis, and causal relationships were evaluated via MR. Multiple machine learning algorithms identified robust biomarkers, which were further validated in external cohorts. Single-cell transcriptome profiling, functional enrichment and molecular docking were performed, followed by in vitro cellular assays. Results We identified 29 overlapping PCa-related targets of NP and OP, among which CDK4, AR, CDKN2A and ABCC4 were prioritized. MR suggested potential causal associations for ABCC4 (OR=1.02, p=0.006) and CDK4 (OR=1.14, p=0.04) with PCa risk. Machine learning (LASSO/SVM-RFE/Boruta) consistently selected ABCC4 and CDK4 as robust biomarkers, validated across independent cohorts. Single-cell analysis of 90,140 cells revealed 15 cell types, with significant expansion of myeloid dendritic cells (mDCs) in tumors. Both biomarkers showed dynamic expression along mDCs differentiation trajectories. Gene enrichment implicated focal adhesion, xenobiotic metabolism, and cell cycle pathways. Molecular docking predicted favorable binding poses for NP and OP with ABCC4 and CDK4, with binding energies below -4.5 kcal/mol. In vitro experiments confirmed that NP promoted PCa cell migration, while OP had no significant effect on cell proliferation. Conclusion ABCC4 and CDK4 may serve as candidate mediators connecting NP/OP exposure with PCa. The expansion and metabolic reprogramming of mDCs suggest that mDCs may participate in tumor microenvironment remodeling in NP/OP-associated PCa. These findings provide molecular insights for environmental PCa prevention and highlight intervention targets.

Frontiers in Public HealthVol. 14
Kunming Medical University (CN), Peking University Cancer Hospital (CN)
Kunming Medical University, Yunnan Provincial Department of Education
Good health and well-being
Effects and risks of endocrine disrupting chemicals
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon